Patents Assigned to BELLEROPHON THERAPEUTICS
  • METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG
    Publication number: 20230201497
    Abstract: Described are methods for providing a pulsed dose of a gaseous drug over a portion of total inspiratory time, where the dose of the gaseous drug is delivered at a concentration of nL of gaseous drug per mL tidal volume.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 29, 2023
    Applicant: BELLEROPHON THERAPEUTICS
    Inventor: Martin DEKKER
  • USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
    Publication number: 20230158064
    Abstract: The present disclosure relates to use of pulsed dose inhaled nitric oxide for treatment of infection, including infection with SARS-CoV2 and the disease state COVID-19.
    Type: Application
    Filed: April 6, 2021
    Publication date: May 25, 2023
    Applicant: BELLEROPHON THERAPEUTICS
    Inventor: Parag SHAH
  • USE OF INHALED NITRIC OXIDE (INO) FOR THE IMPROVEMENT OF SEVERE HYPOXEMIA
    Publication number: 20230158260
    Abstract: Described are methods for improving oxygen saturation in patients suffering from hypoxemia, wherein said patients are receiving a continuous flow of oxygen at 10 L/min and exhibit an initial oxygen saturation of at least about 88%, comprising administering inhaled nitric oxide to said patients in an outpatient setting. Methods for improving quality of life for a hospitalized patient, reducing patient hospitalization time, and reducing costs associated with patient hospitalization are also described.
    Type: Application
    Filed: August 8, 2019
    Publication date: May 25, 2023
    Applicant: BELLEROPHON THERAPEUTICS
    Inventors: Parag SHAH, Deborah QUINN
  • IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT
    Publication number: 20230067942
    Abstract: Described are methods for reducing pulmonary resistance, reducing pulmonary pressure, and increasing pulmonary arterial compliance by providing a inhaled nitric oxide.
    Type: Application
    Filed: January 27, 2021
    Publication date: March 2, 2023
    Applicant: BELLEROPHON THERAPEUTICS
    Inventors: Parag SHAH, Peter FERNANDES
  • COMBINATION DRUG THERAPIES OF PDE-5 INHIBITORS AND INHALED NITRIC OXIDE
    Publication number: 20220096535
    Abstract: Described are methods for treatment of hypertension in combination with pulsed, inhaled nitric oxide.
    Type: Application
    Filed: January 14, 2020
    Publication date: March 31, 2022
    Applicant: BELLEROPHON THERAPEUTICS
    Inventors: Parag SHAH, Peter Paul FERNANDES, Bobae KIM
  • USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONS
    Publication number: 20220080147
    Abstract: Described are methods for maintaining or improving activity levels in patients lung-related conditions.
    Type: Application
    Filed: January 3, 2020
    Publication date: March 17, 2022
    Applicant: BELLEROPHON THERAPEUTICS
    Inventors: Parag SHAH, Peter Paul FERNANDES, Bobae KIM, Martin DEKKER
  • METHOD AND APPARATUS FOR PULSATILE DELIVERY OF NITRIC OXIDE
    Publication number: 20210220586
    Abstract: Described are methods for providing a pulsed dose of nitric oxide during at least the first two-thirds of total inspiratory time in each single breath for a therapeutically relevant period of time.
    Type: Application
    Filed: May 17, 2019
    Publication date: July 22, 2021
    Applicant: BELLEROPHON THERAPEUTICS
    Inventors: Parag SHAH, Martin DEKKER, William LEONARD, Donatas ZUZEVICIUS